| Methods | Type of study: RCT Method of treatment allocation: method of randomisation not stated. Coded drug boxes were provided. Randomisation code was kept on file at the Pharmacy Department of Toronto General Hospital. Stratification: yes, by gestational age into 2 subgroups; 24‐32 weeks and 33‐34 weeks Placebo: yes, vehicle of steroid preparation consisting of 0.2 mg benzalkonium chloride and 0.1 mg disodium edentate per mL Sample size calculation: no Intention‐to‐treat analyses: yes Losses to follow‐up: no Funding: The Hospital for Sick Children Foundation, Canada; Schering Corporation, Canada; Ontario Ministry of Health Provincial Research Grant PR 279, Canada | |
| Participants | Location: 6 teaching hospitals in Toronto, Canada Timeframe: January 1975‐June 1978 Eligibility criteria: women with PROM, spontaneous preterm labour or planned preterm delivery Gestational age range: 24 and 34 weeks. Exclusion criteria: women with pre‐eclampsia or in whom steroids were contraindicated on medical grounds. Total recruited: 137 women and 144 infants; 75 women and 81 infants in the treatment arm and 62 women and 63 infants in the control arm | |
| Interventions | 4 doses of 3 mg betamethasone acetate and 3 mg betamethasone sodium phosphate IM 12 h apart Control group received 4 doses of identical placebo | |
| Outcomes | Fetal/neonatal outcomes were reported (fetal death, neonatal death, RDS, IVH, birthweight, days of mechanical ventilation) | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Method of randomisation not stated |
| Allocation concealment (selection bias) | Low risk | Coded drug boxes were provided. Randomisation code was kept on file at the Pharmacy Department of Toronto General Hospital. |
| Blinding of participants and personnel (performance bias) All outcomes | Low risk | It is likely that participants were blinded as both placebo and corticosteroid solutions were identical. Blinding of study personnel was not described other than to state "double blind". |
| Blinding of outcome assessment (detection bias) All outcomes | Low risk | Blinding of outcome assessors was not described, but is likely as the authors state "The key to the code was not broken until the whole study was completed". |
| Incomplete outcome data (attrition bias) All outcomes | Low risk | No losses to follow‐up |
| Selective reporting (reporting bias) | Low risk | Study protocol not available, but appears to report on all pre‐specified outcomes |
| Other bias | Unclear risk | Insufficient information to asses if other sources of bias exist |